Scientists Identify Drug That Could Be Repurposed To Fight Covid-19
Covid-19 Not Characterised By Cytokine Storm, Specific Anti-Cytokine Therapies Unlikely To Benefit Critical Patients: Study
Nitric Oxide Treatment Could Slow Progression Of Covid-19, Claim Researchers
Biocon Biologics Gets DCGI Nod For Emergency Use Of CytoSorb To Treat Critical Covid-19 Patients
US FDA Authorises Blood Purification Device To Treat COVID-19 Patients With Serious Conditions
